An open, multicentric, post-marketing surveillance study of GlaxoSmithKline Biologicals' combined hepatitis A-hepatitis B vaccine (Twinrix), injected as a three dose primary vaccination course according to the prescribing information, in healthy children and adults

Trial Profile

An open, multicentric, post-marketing surveillance study of GlaxoSmithKline Biologicals' combined hepatitis A-hepatitis B vaccine (Twinrix), injected as a three dose primary vaccination course according to the prescribing information, in healthy children and adults

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2006

At a glance

  • Drugs Hepatitis A-hepatitis B vaccine (Primary)
  • Indications Hepatitis A; Hepatitis B
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 03 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top